Treatment with dual PI3K/mTOR inhibitors or mTOR kinase inhibitors alone or in combination with conventional ALL therapies or with targeted drugs for different cellular cascades inhibits cell proliferation and induces apoptosis by blocking distinct mechanisms of cell survival in ALL [79,83,92]. Here, PIK3CD is linked to acute lymphoblastic leukemia.